A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis

Veterinary Parasitology

Volumn 98, Issue 4, 2001, Pages 247-261

  Koutinas, Alexander F ^a   Saridomichelakis, Manolis N ^a   Mylonakis, Mathios E ^a   Leontides, Leonidas ^b   Polizopoulou, Zoe ^a   Billinis, Charalambos ^a   Argyriadis, Dimitris ^c   Diakou, Natasa ^d   Papadopoulos, Orestis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c Veterinary Research Institute of Thessaloniki   (Greece)

^d Faculty of Veterinary Medicine   (Greece)

Author keywords

Allopurinol; Dog; Leishmania infantum

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMINOID; ALKALINE PHOSPHATASE; ALLOPURINOL; CHOLESTEROL; CREATINE KINASE; CREATININE; GLOBULIN; LACTATE DEHYDROGENASE; PHOSPHORUS; PLACEBO; PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL COUNT; BONE MARROW; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE SEVERITY; DOG; DOSE RESPONSE; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; KIDNEY DISEASE; LEISHMANIA INFANTUM; LEISHMANIASIS; LYMPH NODE; NONHUMAN; POLYMERASE CHAIN REACTION; SAMPLING; SEROLOGY; SERUM; SYMPTOM; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ALLOPURINOL; ANIMALS; ANTIMETABOLITES; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; LEISHMANIASIS; MALE; POLYMERASE CHAIN REACTION;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 0035958829     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(01)00399-5     Document Type: Article

References (56)

1. Canine leishmaniasis: Parasitological and entomological follow-up after chemotherapy
2. Epizootiological study of dog leishmaniasis in central and eastern Macedonia and in Thessaly
3. Ecology and epidemiology: Old world
4. Studies on the control of visceral leishmaniasis: Validation of the Falcon assay screning test-enzyme linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis
5. Comparison of the polymarase chain reaction and serology for the detection of canine visceral leishmaniasis
6. Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy and future strategies
7. Canine leishmaniasis in the Mediterranean area and its implications for human leishmaniasis
8. Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum
9. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis
10. A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum
11. Combination allopurinol and antimony treatment versus antimony alone in the treatment of canine leishmaniasis (96 cases)
12. Parasitologische und immunologische verlaufskkontrollen während und nach chemotherapie der leishmaniose des hundes
13. Epidemiological study of dog parasitosis diagnosed by blood and serological examinations
14. Pharmacologically active drug metabolites: Therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure
15. Leishmaniasis
16. Leishmaniasis: Update in diagnosis and therapy
17. Skin lesions in canine leishmaniasis
18. Serological diagnosis and treatment of canine leishmaniasis
19. Visceral leishmaniasis and disseminated intravascular coagulation in a dog
20. Use of allopurinol for maintenance of remission in dogs with leishmaniasis
21. Leishmania infantum infection rates in Phlebotomus perniciosus fed in infected dogs under antimonial treatment
22. Decreased sensitivity to meglumine antimonate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment
23. Skin lesions in canine leishmaniasis (Kala-Azar): A clinical and histopathological study on 22 spontaneous cases in Greece
24. Canine leishmaniasis-associated nephropathy: A clinical, clinicopathologic and pathologic study in 14 spontaneous cases with proteinuria
25. Clinical considerations on canine visceral leishmaniasis (CVL) in Greece: A retrospective study of 158 spontaneous cases
26. Leishmaniose canine: Du diagnostic au traitement
27. Use of allopurinol to treat visceral leishmaniosis in a dog
28. Allopurinol in the treatment of canine visceral leishmaniasis
29. Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment
30. Comparison between an enzyme-linked immunosorbent assay using a detergent-soluble Leishmania infantum antigen and indirect immunofluorescence for the diagnosis of canine leishmaniosis
31. Epidemiologia de leishmaniasis canina en la provincia de Cordoba
32. Rapid identification od causative species in patients with old world leishmaniasis
33. Metabolism of pyrazolo (3,4-d) pyrimidines in Leishmania braziliensis and Leishmania donovani
34. Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis
35. Canine leishmaniasis
36. Urinary protein/creatinine ratio in the evaluation of renal failure in canine leishmaniasis
37. Drug-induced nephropathies
38. The use of aminosidine in the therapy of leishmaniotic dogs
39. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner
40. Cytokines in a canine model of visceral leishmaniasis. Strategies for the induction of protective immunity
41. Allopurinol
42. Renal involvement in canine leishmaniasis. A light-microscopic, immunohistochemical and electron-microscopic study
43. Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis
44. Electrophoretic profiles in canine leishmaniasis
45. Follow-up of Leishmania infected dogs after treatment using a PCR technique
46. Diagnosis of canine leishmaniasis by a polymerase chain reaction technique
47. Canine leishmaniasis: A review based on 95 cases in the Netherlands
48. Visceral leishmaniasis in dogs in Europe
49. The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime®) in dogs with leishmaniasis. A randomized clinical trial
50. Leishmaniasis
51. First evaluation of the use of allopurinol for the treatment of canine leishmaniosis
52. Development of a slide ELISA for canine leishmasniasis and comparison with four serological tests
53. Control of leishmaniases
54. Epidemiological patterns of canine leishmaniasis in Western Liguria (Italy)